S&P 500   2,993.19 (+0.12%)
DOW   26,980.60 (-0.08%)
QQQ   192.98 (-0.03%)
AAPL   233.62 (-0.32%)
MSFT   139.08 (-0.95%)
GOOGL   1,251.81 (+0.71%)
AMZN   1,787.95 (+0.59%)
CGC   20.17 (+2.23%)
BABA   176.38 (-0.42%)
GE   9.08 (+1.91%)
TSLA   260.99 (+0.48%)
T   37.64 (-0.42%)
F   9.11 (+0.44%)
ACB   3.80 (+5.26%)
NFLX   296.69 (+3.64%)
BAC   30.04 (-0.43%)
GILD   65.06 (-0.44%)
DIS   132.72 (+1.42%)
S&P 500   2,993.19 (+0.12%)
DOW   26,980.60 (-0.08%)
QQQ   192.98 (-0.03%)
AAPL   233.62 (-0.32%)
MSFT   139.08 (-0.95%)
GOOGL   1,251.81 (+0.71%)
AMZN   1,787.95 (+0.59%)
CGC   20.17 (+2.23%)
BABA   176.38 (-0.42%)
GE   9.08 (+1.91%)
TSLA   260.99 (+0.48%)
T   37.64 (-0.42%)
F   9.11 (+0.44%)
ACB   3.80 (+5.26%)
NFLX   296.69 (+3.64%)
BAC   30.04 (-0.43%)
GILD   65.06 (-0.44%)
DIS   132.72 (+1.42%)
Log in

West Pharmaceutical Services Stock Price, News & Analysis (NYSE:WST)

$142.18
+2.21 (+1.58 %)
(As of 10/17/2019 12:08 PM ET)
Today's Range
$140.86
Now: $142.18
$142.61
50-Day Range
$137.35
MA: $143.35
$151.17
52-Week Range
$91.75
Now: $142.18
$152.10
Volume89,599 shs
Average Volume384,525 shs
Market Capitalization$10.49 billion
P/E Ratio50.60
Dividend Yield0.42%
Beta1.28
West Pharmaceutical Services, Inc manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, South Korea, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, and washing and sterilization processes and services to enhance the quality of packaging components. Read More…

Industry, Sector and Symbol

Industry Fabricated rubber products, not elsewhere classified
Sub-IndustryHealth Care Supplies
SectorMedical
CUSIP95530610
Phone610-594-2900

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.72 billion
Cash Flow$4.28 per share
Book Value$18.85 per share

Profitability

Net Income$206.90 million

Miscellaneous

Employees7,700
Market Cap$10.49 billion
Next Earnings Date10/24/2019 (Confirmed)
OptionableOptionable

Receive WST News and Ratings via Email

Sign-up to receive the latest news and ratings for WST and its competitors with MarketBeat's FREE daily newsletter.


West Pharmaceutical Services (NYSE:WST) Frequently Asked Questions

What is West Pharmaceutical Services' stock symbol?

West Pharmaceutical Services trades on the New York Stock Exchange (NYSE) under the ticker symbol "WST."

How often does West Pharmaceutical Services pay dividends? What is the dividend yield for West Pharmaceutical Services?

West Pharmaceutical Services announced a quarterly dividend on Thursday, July 25th. Stockholders of record on Wednesday, October 23rd will be given a dividend of $0.15 per share on Wednesday, November 6th. This represents a $0.60 annualized dividend and a dividend yield of 0.42%. The ex-dividend date of this dividend is Tuesday, October 22nd. View West Pharmaceutical Services' Dividend History.

How will West Pharmaceutical Services' stock buyback program work?

West Pharmaceutical Services announced that its Board of Directors has authorized a share repurchase plan on Thursday, February 15th 2018, which authorizes the company to buyback 800,000 outstanding shares, according to EventVestor. This buyback authorization authorizes the company to purchase shares of its stock through open market purchases. Shares buyback plans are often a sign that the company's board of directors believes its stock is undervalued.

How were West Pharmaceutical Services' earnings last quarter?

West Pharmaceutical Services Inc. (NYSE:WST) released its quarterly earnings data on Thursday, July, 25th. The medical instruments supplier reported $0.89 EPS for the quarter, beating analysts' consensus estimates of $0.72 by $0.17. The medical instruments supplier earned $469.70 million during the quarter, compared to analysts' expectations of $459.90 million. West Pharmaceutical Services had a net margin of 12.94% and a return on equity of 16.93%. The firm's quarterly revenue was up 5.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.70 earnings per share. View West Pharmaceutical Services' Earnings History.

When is West Pharmaceutical Services' next earnings date?

West Pharmaceutical Services is scheduled to release their next quarterly earnings announcement on Thursday, October 24th 2019. View Earnings Estimates for West Pharmaceutical Services.

How can I listen to West Pharmaceutical Services' earnings call?

West Pharmaceutical Services will be holding an earnings conference call on Thursday, October 24th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What guidance has West Pharmaceutical Services issued on next quarter's earnings?

West Pharmaceutical Services updated its FY19 earnings guidance on Thursday, July, 25th. The company provided earnings per share guidance of $3.00-3.10 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.89. The company issued revenue guidance of $1.810-1.825 billion, compared to the consensus revenue estimate of $1.81 billion.

What price target have analysts set for WST?

3 brokers have issued twelve-month price objectives for West Pharmaceutical Services' stock. Their forecasts range from $112.16 to $122.00. On average, they anticipate West Pharmaceutical Services' stock price to reach $117.08 in the next twelve months. This suggests that the stock has a possible downside of 17.7%. View Analyst Price Targets for West Pharmaceutical Services.

What is the consensus analysts' recommendation for West Pharmaceutical Services?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for West Pharmaceutical Services in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for West Pharmaceutical Services.

Has West Pharmaceutical Services been receiving favorable news coverage?

Media coverage about WST stock has been trending very negative on Thursday, according to InfoTrie Sentiment. The research firm identifies positive and negative media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. West Pharmaceutical Services earned a media sentiment score of -3.2 on InfoTrie's scale. They also assigned press coverage about the medical instruments supplier a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for West Pharmaceutical Services.

Who are some of West Pharmaceutical Services' key competitors?

What other stocks do shareholders of West Pharmaceutical Services own?

Based on aggregate information from My MarketBeat watchlists, some companies that other West Pharmaceutical Services investors own include Johnson & Johnson (JNJ), Mcdonald's (MCD), Nike (NKE), PepsiCo (PEP), Lowe's Companies (LOW), Medtronic (MDT), Stanley Black & Decker (SWK), NVIDIA (NVDA), AFLAC (AFL) and CVS Health (CVS).

Who are West Pharmaceutical Services' key executives?

West Pharmaceutical Services' management team includes the folowing people:
  • Mr. Eric M. Green, CEO, Pres & Director (Age 49)
  • Mr. David A. Montecalvo, Sr. VP and Chief Operations & Supply Chain Officer (Age 54)
  • Mr. George Lloyd Miller, Sr. VP, Gen. Counsel & Corp. Sec. (Age 64)
  • Ms. Karen A. Flynn, Chief Commercial Officer & Sr. VP (Age 56)
  • Mr. William J. Federici, Advisor (Age 59)

Who are West Pharmaceutical Services' major shareholders?

West Pharmaceutical Services' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Riverbridge Partners LLC (0.80%), Pacer Advisors Inc. (0.04%), State of Alaska Department of Revenue (0.02%), Crossmark Global Holdings Inc. (0.01%), Fox Run Management L.L.C. (0.01%) and Summit Creek Advisors LLC (0.01%). Company insiders that own West Pharmaceutical Services stock include Daniel Malone, Karen Flynn, Patrick J Zenner and William J Federici. View Institutional Ownership Trends for West Pharmaceutical Services.

Which institutional investors are selling West Pharmaceutical Services stock?

WST stock was sold by a variety of institutional investors in the last quarter, including Pacer Advisors Inc., Financial Gravity Wealth Inc., Crossmark Global Holdings Inc. and Mission Wealth Management LP. View Insider Buying and Selling for West Pharmaceutical Services.

Which institutional investors are buying West Pharmaceutical Services stock?

WST stock was bought by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, Fox Run Management L.L.C., State of Alaska Department of Revenue, Summit Creek Advisors LLC, Advisor Partners LLC, Campbell & CO Investment Adviser LLC, Diversified Trust Co and First Hawaiian Bank. View Insider Buying and Selling for West Pharmaceutical Services.

How do I buy shares of West Pharmaceutical Services?

Shares of WST can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is West Pharmaceutical Services' stock price today?

One share of WST stock can currently be purchased for approximately $142.18.

How big of a company is West Pharmaceutical Services?

West Pharmaceutical Services has a market capitalization of $10.49 billion and generates $1.72 billion in revenue each year. The medical instruments supplier earns $206.90 million in net income (profit) each year or $2.81 on an earnings per share basis. West Pharmaceutical Services employs 7,700 workers across the globe.View Additional Information About West Pharmaceutical Services.

What is West Pharmaceutical Services' official website?

The official website for West Pharmaceutical Services is http://www.westpharma.com/.

How can I contact West Pharmaceutical Services?

West Pharmaceutical Services' mailing address is 530 HERMAN O. WEST DRIVE, EXTON PA, 19341. The medical instruments supplier can be reached via phone at 610-594-2900 or via email at [email protected]


MarketBeat Community Rating for West Pharmaceutical Services (NYSE WST)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  212 (Vote Outperform)
Underperform Votes:  332 (Vote Underperform)
Total Votes:  544
MarketBeat's community ratings are surveys of what our community members think about West Pharmaceutical Services and other stocks. Vote "Outperform" if you believe WST will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WST will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel